| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/27/2023 | Coya Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 115k | $3.85 | $442.8k | | 02/27/2023 |
| 01/03/2023 | Coya Therapeutics, Inc. | | Purchase | Common Stock, par value $0.0001 per share | 10k | $0.00 | $0 | | 01/03/2023 |
| 01/03/2023 | Coya Therapeutics, Inc. | | Purchase | Warrant to Purchase Common Stock | 5k | $7.50 | $37.5k | | 01/03/2023 |
| 01/23/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 1.6k | $57.98 | $94.5k | | 01/23/2020 |
| 01/07/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 815 | $57.38 | $46.8k | | 01/05/2020 |
| 01/05/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 24k | $0.00 | $0 | | 01/05/2020 |
| 01/05/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Employee Stock Option (right to buy) | 55k | $59.80 | $3.3M | | 01/05/2020 |
| 01/23/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Employee Stock Option (right to buy) | 42.5k | $42.40 | $1.8M | | 01/07/2019 |
| 01/23/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 19k | $0.00 | $0 | | 01/07/2019 |
| 01/07/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 771 | $41.33 | $31.9k | | 01/07/2019 |
| 01/07/2018 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Performance Stock Unit | 27k | $0.00 | $0 | | 01/07/2018 |
| 01/07/2018 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Employee Stock Option (Right to Buy) | 43k | $59.14 | $2.5M | | 01/07/2018 |
| 01/07/2018 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 9k | $0.00 | $0 | | 01/07/2018 |
| 01/04/2017 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Stock Option (right to buy) | 67.2k | $84.92 | $5.7M | | 01/04/2017 |